Company intelligence / Profile preview

Biosystemix

Kingston, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Biosystemix is a specialized bioinformatics and systems biology company that provides data-driven solutions for personalized medicine. Founded by experts in computational biology, the firm utilizes advanced machine learning, signal processing, and mathematical modeling to transform complex genomic and clinical data into predictive medical insights. Their services include biomarker discovery, therapeutic response prediction, and the development of molecular diagnostic and prognostic tests. Biosystemix has established partnerships with academic and clinical institutions to advance research in oncology, infectious diseases, and critical care.

Therapeutic areas: OncologyOtherInfectious Diseases
Modalities: Small moleculeVaccineBiologic
Industry: Drug Discovery Services

Partnerships

Genome QuebecGenome CanadaPRIVAC Partnership Project

Beyond the preview

Go deeper on Biosystemix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biosystemix.

Explore the full profile